Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

✍ Scribed by Craig L Leonardi; Alexa B Kimball; Kim A Papp; Newman Yeilding; Cynthia Guzzo; Yuhua Wang; Shu Li; Lisa T Dooley; Kenneth B Gordon

• Book ID: 117302960
• Publisher: The Lancet
• Year: 2008
• Tongue: English
• Weight: 222 KB
• Volume: 371
• Category: Article
• ISSN: 0140-6736
• DOI: 10.1016/s0140-6736(08)60725-4